TRACKING COVID IN HISD

Houston Independent School District launches new COVID-19 tracker

HISD's new dashboard will track active COVID-19 cases. Photo by Klaus Vedfelt/Getty Images

Greater Houston parents have an important date circled and marked on their calendars: October 19. That's the day Houston Independent School District welcomes students back for in-person instruction at all schools.

However, a major point of concern and contention with area parents is the possibility of fellow students contracting, carrying, and spreading COVID-19. To that end, the district has announced a new COVID-19 dashboard to keep the community informed about the impact of the pandemic. Parents can view the COVID-19 dashboard here.

The online dashboard launched Monday, September 28, to track the number of confirmed COVID-19 students and staff cases on campuses, in an effort to display transparency, according to a press release. As of September 28, some 23 active cases are reflected on the dashboard, out of more than 222,000 students and staff.

HISD's new dashboard was developed using Texas Education Agency guidelines for reporting COVID-19. It will be updated daily, allowing users to review student and staff data by location and districtwide, according to the district. The dashboard will also include a map to clearly illustrate and mark active cases throughout the district.

All applicable privacy laws relating to the release of personal health information will be followed, according to a press release.

"As we navigate this pandemic together, we want to ensure that we are transparent as we provide crucial updates," said HISD interim superintendent, Grenita Lathan, in a statement. "This new dashboard will give our staff members and families the information they need in an accessible and easy-to-use way to make informed decisions."

For more information on HISD's reopening plan, visit the official site.

------

This article originally ran on CultureMap.

Trending News

Building Houston

 
 

Dr. Peter Hotez and Dr. Maria Elena Bottazzi have been recognized by Fast Company for their leadership in developing low-cost COVID vaccine. Photo courtesy of Texas Children's

This week, Fast Company announced its 14th annual list of Most Creative People in Business — and two notable Houstonians made the cut.

Dr. Peter Hotez and his fellow dean of the National School of Tropical Medicine at Baylor College of Medicine, Dr. Maria Elena Bottazzi, were named among the list for “open sourcing a COVID-19 Vaccine for the rest of the world.” The list, which recognizes individuals making a cultural impact via bold achievements in their field, is made up of influential leaders in business.

Hotez and Bottazzi are also co-directors for the Texas Children's Hospital's Center for Vaccine Development -one of the most cutting-edge vaccine development centers in the world. For the past two decades it has acquired an international reputation as a non-profit Product Development Partnership (PDP), advancing vaccines for poverty-related neglected tropical diseases (NTDs) and emerging infectious diseases of pandemic importance. One of their most notable achievements is the development of a vaccine technology leading to CORBEVAX, a traditional, recombinant protein-based COVID-19 vaccine.

"It's an honor to be recognized not only for our team's scientific efforts to develop and test low cost-effective vaccines for global health, but also for innovation in sustainable financing that goes beyond the traditional pharma business model," says Hotez in a statement.

The technology was created and engineered by Texas Children's Center for Vaccine Development specifically to combat the worldwide problem of vaccine access and availability. Biological E Limited (BE) developed, produced and tested CORBEVAX in India where over 60 million children have been vaccinated so far.

Earlier this year, the doctors were nominated for the 2022 Nobel Peace Prize for their research and vaccine development of the vaccine. Its low cost, ease of production and distribution, safety, and acceptance make it well suited for addressing global vaccine inequity.

"We appreciate the recognition of our efforts to begin the long road to 'decolonize' the vaccine development ecosystem and make it more equitable. We hope that CORBEVAX becomes one of a pipeline of new vaccines developed against many neglected and emerging infections that adversely affect global public health," says Bottazzi in the news release from Texas Children's.

Fast Company editors and writers research candidates for the list throughout the year, scouting every business sector, including technology, medicine, engineering, marketing, entertainment, design, and social good. You can see the complete list here

.

Trending News